These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 25085455

  • 1. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G, Huang F, Sloboda R, Pearcey R, Ghosh S.
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [Abstract] [Full Text] [Related]

  • 2. Sci-Sat AM: Brachy - 08: MRI-guided planning and maximum achievable HR-CTV doses in cervix brachytherapy.
    Menon G, Sloboda R, Ghosh S, Dundas G, Pearcey R, Huang F.
    Med Phys; 2012 Jul; 39(7Part4):4646. PubMed ID: 28516636
    [Abstract] [Full Text] [Related]

  • 3. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M, Fields EC, Todor DA.
    Brachytherapy; 2015 Jul; 14(5):613-8. PubMed ID: 26092424
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS, Vestergaard A, Kallehauge JF, Mohamed S, Nielsen SK, Petersen JB, Fokdal L, Lindegaard JC, Tanderup K.
    Brachytherapy; 2014 Jul; 13(4):361-8. PubMed ID: 24656732
    [Abstract] [Full Text] [Related]

  • 6. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH, Polan D, Vineberg K, Jolly S, Maturen KE, Brock KK, Prisciandaro JI.
    Brachytherapy; 2018 Jul; 17(2):360-367. PubMed ID: 29331573
    [Abstract] [Full Text] [Related]

  • 7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I, Janssen H, De Brabandere M, Nulens A, De Bal D, Vergote I, Van Limbergen E.
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
    Park SJ, Chung M, Demanes DJ, Banerjee R, Steinberg M, Kamrava M.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):840-6. PubMed ID: 24138921
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H, Kinard J, Maurer J, Shang Q, Vanderstraeten C, Hayes L, Sintay B, Wiant D.
    J Appl Clin Med Phys; 2018 Nov 15; 19(6):316-322. PubMed ID: 30284370
    [Abstract] [Full Text] [Related]

  • 13. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
    Nishikawa R, Yoshida K, Ebina Y, Omoteda M, Miyawaki D, Ishihara T, Ejima Y, Akasaka H, Satoh H, Kyotani K, Takahashi S, Sasaki R.
    J Radiat Res; 2018 May 01; 59(3):316-326. PubMed ID: 29518234
    [Abstract] [Full Text] [Related]

  • 14. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN, de Leeuw AA, Van Limbergen E, de Brabandere M, Nulens A, Nout RA, Laman M, Ketelaars M, Lutgens L, Reniers B, Jürgenliemk-Schulz IM.
    Radiother Oncol; 2013 Apr 01; 107(1):82-7. PubMed ID: 23127774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
    Paton AM, Chalmers KE, Coomber H, Cameron AL.
    Br J Radiol; 2012 Dec 01; 85(1020):e1249-55. PubMed ID: 23175490
    [Abstract] [Full Text] [Related]

  • 18. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
    Dincer N, Ugurluer G, Mustafayev TZ, Serkizyan A, Aydin G, Güngör G, Yapici B, Atalar B, Özyar E.
    Brachytherapy; 2024 Dec 01; 23(1):18-24. PubMed ID: 38000958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Simha V, Rai B, Patel FD, Kapoor R, Sharma SC, Singh OA, Singla V, Dhanireddy B, Ghoshal S.
    Brachytherapy; 2018 Dec 01; 17(2):345-351. PubMed ID: 29102740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.